Dysregulation of Ephrin receptor and PPAR signaling pathways in neural progenitor cells infected by Zika virus.


Journal

Emerging microbes & infections
ISSN: 2222-1751
Titre abrégé: Emerg Microbes Infect
Pays: United States
ID NLM: 101594885

Informations de publication

Date de publication:
Dec 2020
Historique:
pubmed: 3 9 2020
medline: 22 4 2021
entrez: 3 9 2020
Statut: ppublish

Résumé

Zika virus (ZIKV) infection is a serious public threat with cases reported in about 70 countries and territories. One of the most serious consequences of ZIKV infection is congenital microcephaly in babies. Congenital microcephaly has been suggested to result from infection of neural progenitor cells (NPCs) in the developing fetal brain. However, the molecular and cellular mechanisms underlying microcephaly development remains to be fully elucidated. In this study, we employed quantitative proteomics to determine protein expression profile that occur during viral replication in NPCs. Bioinformatics analysis of the protein expression changes resulted in the identification of a wide range of cell signaling pathways. Specifically, pathways involved in neurogenesis and embryonic development were markedly altered, along with those associated with cell cycle, apoptosis, lipid metabolism and oxidative stress. Notably, the differential regulation of Ephrin Receptor and PPAR signaling pathways, as revealed by quantitative proteomics and validated by qPCR array, underscores the need to explore these pathways in disease development. Collectively, these results indicate that ZIKV-induced pathogenesis involves complex virus-host reactions; the findings reported here could help shed light on the mechanisms underlying ZIKV-induced microcephaly and ZIKV replication in NPCs.

Identifiants

pubmed: 32873194
doi: 10.1080/22221751.2020.1818631
pmc: PMC7534353
doi:

Substances chimiques

Peroxisome Proliferator-Activated Receptors 0
Receptors, Eph Family EC 2.7.10.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2046-2060

Références

Am J Physiol Regul Integr Comp Physiol. 2000 Aug;279(2):R515-21
pubmed: 10938240
Viruses. 2017 Jan 19;9(1):
pubmed: 28106839
Annu Rev Cell Dev Biol. 1997;13:513-609
pubmed: 9442882
Expert Rev Anti Infect Ther. 2018 May;16(5):399-410
pubmed: 29668332
Small GTPases. 2017 Apr 3;8(2):106-113
pubmed: 27492682
Int J Mol Sci. 2018 Jun 26;19(7):
pubmed: 29949869
PLoS Pathog. 2014 Dec 11;10(12):e1004534
pubmed: 25502789
Front Cell Neurosci. 2018 Jun 14;12:165
pubmed: 29962938
Front Microbiol. 2017 Feb 20;8:240
pubmed: 28265266
J Virol. 2015 Oct;89(19):9932-8
pubmed: 26202243
Cell Mol Biol Lett. 2016 Sep 20;21:18
pubmed: 28536620
Cell Microbiol. 2007 Oct;9(10):2445-56
pubmed: 17517063
Front Immunol. 2018 Jun 04;9:1276
pubmed: 29915602
Travel Med Infect Dis. 2019 Jan - Feb;27:121-122
pubmed: 30399445
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
J Med Virol. 2019 Feb;91(2):179-189
pubmed: 30192399
Stem Cell Reports. 2019 Dec 10;13(6):1111-1125
pubmed: 31813826
Nature. 2013 Jan 10;493(7431):226-30
pubmed: 23201681
Emerg Infect Dis. 2016 May;22(5):933-5
pubmed: 27088323
Cell Adh Migr. 2014;8(4):349-59
pubmed: 25482631
Nat Cell Biol. 2000 Jul;2(7):435-40
pubmed: 10878809
EBioMedicine. 2019 Mar;41:134-145
pubmed: 30755372
J Infect Dis. 2017 Sep 15;216(6):703-712
pubmed: 28934431
Lipids Health Dis. 2016 Oct 22;15(1):184
pubmed: 27770802
Biomed Res Int. 2015;2015:727542
pubmed: 26421301
Front Microbiol. 2018 Jun 05;9:1067
pubmed: 29922247
Emerg Microbes Infect. 2017 Apr 26;6(4):e24
pubmed: 28442752
J Med Virol. 2019 Sep;91(9):1584-1594
pubmed: 31095749
Infect Genet Evol. 2019 Apr;69:22-29
pubmed: 30658214
Biochem Pharmacol. 2016 Aug 15;114:69-81
pubmed: 27060663
Cell Host Microbe. 2013 Apr 17;13(4):375-7
pubmed: 23601099
Nature. 2018 Sep;561(7722):253-257
pubmed: 30177828
J Adv Pharm Technol Res. 2011 Oct;2(4):236-40
pubmed: 22247890
Cell Stem Cell. 2017 Mar 2;20(3):397-406.e5
pubmed: 28132835
Nature. 2001 Nov 1;414(6859):112-7
pubmed: 11689956
J Cell Biochem. 2018 Aug;119(8):6366-6382
pubmed: 29737559
F1000Res. 2016 Mar 30;5:
pubmed: 27092247
J Virol. 2006 Mar;80(6):2976-86
pubmed: 16501107
Cell Mol Life Sci. 2020 Jun;77(12):2355-2365
pubmed: 31893311
Crit Rev Microbiol. 2019 Sep - Nov;45(5-6):495-513
pubmed: 30663919
Development. 2018 May 14;145(10):
pubmed: 29759980
Mol Cell Biol. 2004 Nov;24(22):9705-25
pubmed: 15509776
PLoS Negl Trop Dis. 2019 Jun 6;13(6):e0007387
pubmed: 31170143
Virology. 2015 Nov;485:439-51
pubmed: 26351203
Cell Mol Life Sci. 2020 Jul;77(13):2483-2496
pubmed: 31912194
Nature. 2009 May 21;459(7245):356-63
pubmed: 19458711
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11836-41
pubmed: 12189208
Cell Rep. 2017 Feb 28;18(9):2113-2123
pubmed: 28249158
Int J Mol Sci. 2018 Jan 26;19(2):
pubmed: 29373545
JAMA Pediatr. 2020 Mar 1;174(3):269-276
pubmed: 31904798
Viruses. 2017 Nov 23;9(12):
pubmed: 29168732
Sci Signal. 2020 Jun 09;13(635):
pubmed: 32518143
CNS Neurol Disord Drug Targets. 2018;17(2):78-86
pubmed: 29422006
J Virol. 2019 Jun 14;93(13):
pubmed: 31019057
BMC Neurosci. 2007 May 25;8:36
pubmed: 17531091
Sci Rep. 2018 Oct 19;8(1):15486
pubmed: 30341327
Neuropsychopharmacology. 2010 Jan;35(1):147-68
pubmed: 19794405

Auteurs

Sathya N Thulasi Raman (SN)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Elyse Latreille (E)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Jun Gao (J)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Wanyue Zhang (W)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Jianguo Wu (J)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Marsha S Russell (MS)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Lisa Walrond (L)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Terry Cyr (T)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Jessie R Lavoie (JR)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

David Safronetz (D)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Jingxin Cao (J)

National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.

Simon Sauve (S)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Aaron Farnsworth (A)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.

Wangxue Chen (W)

National Research Council of Canada, Human Health Therapeutics, Ottawa, ON, Canada.

Pei-Yong Shi (PY)

Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

Youchun Wang (Y)

National Institute for Food and Drug Control and WHO Collaborating Center for Standardization and Evaluation of Biologicals, Beijing, People's Republic of China.

Lisheng Wang (L)

Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Michael Rosu-Myles (M)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Xuguang Li (X)

Centre for Biologics Evaluation, Biologics and Radiopharmaceutical Drugs Directorate, HPFB, Health Canada and WHO Collaborating Centre for Standardization and Evaluation of Biologicals, Ottawa, ON, Canada.
Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH